| Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, ... J Clin Oncol, JCO2001933-JCO2001933, 2021 | 261 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study C collaborative the Lancet oncology, 2021 | 247 | 2021 |
| Colorectal liver metastases: Current management and future perspectives J Martin, A Petrillo, EC Smyth, N Shaida, S Khwaja, HK Cheow, ... World Journal of Clinical Oncology 11 (10), 761, 2020 | 146 | 2020 |
| Triple-negative breast cancers: systematic review of the literature on molecular and clinical features with a focus on treatment with innovative drugs A Diana, E Franzese, S Centonze, F Carlino, CM Della Corte, J Ventriglia, ... Current oncology reports 20, 1-11, 2018 | 112 | 2018 |
| Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic C Collaborative British Journal of Surgery 108 (1), 88-96, 2021 | 95 | 2021 |
| Repurposing anticancer drugs for the management of COVID-19 K El Bairi, D Trapani, A Petrillo, C Le Page, H Zbakh, B Daniele, ... European Journal of Cancer 141, 40-61, 2020 | 81 | 2020 |
| Perioperative treatment in resectable gastric cancer: current perspectives and future directions A Petrillo, L Pompella, G Tirino, A Pappalardo, MM Laterza, M Caterino, ... Cancers 11 (3), 399, 2019 | 67 | 2019 |
| Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic C Collaborative, JC Glasbey, D Nepogodiev, JFF Simoes, OM Omar, ... Colorectal Disease, 2020 | 66* | 2020 |
| Immune checkpoint inhibitors in hepatocellular carcinoma: current status and novel perspectives P Federico, A Petrillo, P Giordano, D Bosso, A Fabbrocini, M Ottaviano, ... Cancers 12 (10), 3025, 2020 | 64 | 2020 |
| NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice F De Vita, J Ventriglia, A Febbraro, MM Laterza, A Fabozzi, B Savastano, ... BMC cancer 16, 1-8, 2016 | 62 | 2016 |
| Clinical management of advanced gastric cancer: the role of new molecular drugs F De Vita, N Di Martino, A Fabozzi, MM Laterza, J Ventriglia, B Savastano, ... World Journal of Gastroenterology: WJG 20 (40), 14537, 2014 | 58 | 2014 |
| Pancreatic neuroendocrine tumors: Nosography, management and treatment M Orditura, A Petrillo, J Ventriglia, A Diana, MM Laterza, A Fabozzi, ... International Journal of Surgery 28, S156-S162, 2016 | 56 | 2016 |
| Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer G Bruixola, J Caballero, F Papaccio, A Petrillo, A Iranzo, M Civera, ... ESMO open 3 (6), e000425, 2018 | 54 | 2018 |
| What’s new in gastric cancer: the therapeutic implications of molecular classifications and future perspectives G Tirino, L Pompella, A Petrillo, MM Laterza, A Pappalardo, M Caterino, ... International Journal of Molecular Sciences 19 (9), 2659, 2018 | 48 | 2018 |
| Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic C collaborative British journal of surgery, 2021 | 43 | 2021 |
| Ramucirumab as second-line therapy in metastatic gastric cancer: real-world data from the RAMoss study M Di Bartolomeo, M Niger, G Tirino, A Petrillo, R Berenato, MM Laterza, ... Targeted Oncology 13, 227-234, 2018 | 42 | 2018 |
| Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer J van de Haar, X Ma, SN Ooft, PW van der Helm, LR Hoes, S Mainardi, ... Nature Medicine 29 (3), 605-614, 2023 | 38 | 2023 |
| Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study C Fotopoulou, T Khan, J Bracinik, J Glasbey, N Abu-Rustum, L Chiva, ... American Journal of Obstetrics & Gynecology 227 (5), 735. e1-735. e25, 2022 | 33 | 2022 |
| Multimodality treatment for localized gastric cancer: state of the art and new insights A Petrillo, EC Smyth Current Opinion in Oncology 32 (4), 347-355, 2020 | 31 | 2020 |
| Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer F Morgillo, F De Vita, G Antoniol, M Orditura, PP Auriemma, MR Diadema, ... Current oncology 20 (4), 283-288, 2013 | 30 | 2013 |
Ferdinando De VitaProfessore di Oncologia Medica在 unicampania.it 的电子邮件经过验证
